Berberrubine

CAS# 15401-69-1

Berberrubine

Catalog No. BCN2651----Order now to get a substantial discount!

Product Name & Size Price Stock
Berberrubine: 5mg $58 In Stock
Berberrubine: 10mg Please Inquire In Stock
Berberrubine: 20mg Please Inquire Please Inquire
Berberrubine: 50mg Please Inquire Please Inquire
Berberrubine: 100mg Please Inquire Please Inquire
Berberrubine: 200mg Please Inquire Please Inquire
Berberrubine: 500mg Please Inquire Please Inquire
Berberrubine: 1000mg Please Inquire Please Inquire

Quality Control of Berberrubine

Number of papers citing our products

Chemical structure

Berberrubine

3D structure

Chemical Properties of Berberrubine

Cas No. 15401-69-1 SDF Download SDF
PubChem ID 72703 Appearance Yellow-orange powder
Formula C19H16NO4+ M.Wt 322.33
Type of Compound Alkaloids Storage Desiccate at -20°C
Synonyms 9-Berberoline chloride; Beroline chloride; 9-Demethoxy 9-hydroxyberberinium chloride
Solubility Soluble in methan
SMILES COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)O.[Cl-]
Standard InChIKey GYFSYEVKFOOLFZ-UHFFFAOYSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Berberrubine

1 Phellodendron sp. 2 Zanthoxylum sp.

Biological Activity of Berberrubine

DescriptionBerberrubine possesses diverse pharmacological activities, including glucose-lowering, lipid-lowering, anti-inflammatory, and anti-tumor effects. Berberrubine dose-dependently inhibits IL-8 and MCP-1 protein levels in the media and mRNA expression of the cells stimulated with IL-1beta or TNF-alpha.
TargetsLDL | IL Receptor | TNF-α | NF-kB | MCP-1
In vitro

Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line.[Pubmed: 16797033]

Life Sci. 2006 Aug 1;79(10):949-56.

We examined the effects of Berberrubine, a protoberberine alkaloid, on interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) expression in a human retinal pigment epithelial cell line (ARPE-19) stimulated with interleukin-1beta (IL-1beta) or tumor necrosis factor alpha (TNF-alpha).
CONCLUSIONS:
ARPE-19 cells were cultured to confluence. Berberrubine and IL-1beta or TNF-alpha were added to the medium. IL-8 and MCP-1 protein concentrations were measured using enzyme-linked immunosorbent assay. IL-8 and MCP-1 mRNA were measured by real time polymerase chain reaction. Nuclear factor kappaB (NF-kappaB) translocation was examined by immunofluorescent staining/microscopy. Berberrubine dose-dependently inhibited IL-8 and MCP-1 protein levels in the media and mRNA expression of the cells stimulated with IL-1beta or TNF-alpha. Immunofluorescent staining/microscopy of NF-kappaB in the nucleus of unstimulated cells was faint (51+/-14 arbitrary units). Fluorescein was dense (215+/-42 or 170+/-24 arbitrary units, respectively) 30 min after stimulation with IL-1beta or TNF-alpha and was decreased to 62+/-18 or 47+/-16 arbitrary units, respectively, by Berberrubine.
CONCLUSIONS:
Berberrubine dose-dependently inhibited IL-8 and MCP-1 expression and protein secretion induced by IL-1beta or TNF-alpha. Possibly, the effect on chemotactic factors may be via suppression of NF-kappaB translocation.

In vivo

Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.[Pubmed: 20673726]

Bioorg Med Chem. 2010 Sep 1;18(17):6422-8.


METHODS AND RESULTS:
In order to enhance oral bioavailability of berberine (BBR) for its cholesterol-lowering efficacy in vivo, a series of ester or ether prodrugs of Berberrubine (M1), which is an active metabolite of BBR after first-pass metabolism, were designed, semi-synthesized, and evaluated. Among these Berberrubine prodrugs, compound 5g possessing palmitate at the 9-position showed a moderate LogP value and esterase hydrolysis rate for releasing Berberrubine in blood. Its cholesterol-lowering efficacy in vivo was evaluated in hyperlipidemic SD rats. Compound 5g (100mg/kg/d) reduced blood CHO and LDL-c by 35.8% and 45.5%, respectively, similar to that by BBR. It also exhibited a good safety in rats with no side-effect on liver and kidney function.
CONCLUSIONS:
Therefore, the design of Berberrubine prodrug appears to be an effective strategy to improve pharmacokinetic feature of BBR for its lipid-lowering efficacy in vivo.

Protocol of Berberrubine

Cell Research

Antitumor activity of berberrubine derivatives.[Pubmed: 964560]

Gan. 1976 Apr;67(2):321-5.


METHODS AND RESULTS:
The antitumor activity of berberine, Berberrubine, and their derivatives against sarcoma-180 ascites was determined by the total packed cell volume method. Berbine and tetrahydroberberine derivatives had no antitumor activity, but Berberrubine (9-demethylberberine) and the ester derivatives of Berberrubine had a strong antitumor activity. ED90 of Berberrubine, its acetate and benzoate, were 15, 23, and 44 mg/kg, respectively.
CONCLUSIONS:
The therapeutic indices (LD10/ED90 by the present method) of these compounds were as follows: Berberrubine hydrochloride, 6.7 approximately 9.4; 9-acetyl-9-demethylberberine (9-acetylBerberrubine) chloride, 7.6 approximately 8.7; 9-benzoyl-9-demethylberberine (9-benzoylBerberrubine) chloride, 3.4 approximately 4.9.

Structure Identification
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1762-5.

Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabetics.[Pubmed: 24613165]


METHODS AND RESULTS:
By introducing various amino methyl groups into 12-position of Berberrubine, a series of 12-(substituted aminomethyl) Berberrubine derivatives were synthesized and evaluated for their anti-diabetic activity against type 2 diabetes mellitus. The results indicated that most of the prepared compounds exhibited moderate to good anti-diabetic activity, which were comparable to or even better than the berberine, the positive control rosiglitazone and insulin.
CONCLUSIONS:
Especially, compound 3b with an N-methyl piperazine-4-methyl group at C-12, exerted the most powerful anti-diabetic activity.

Berberrubine Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Berberrubine Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Berberrubine

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.1024 mL 15.5121 mL 31.0241 mL 62.0482 mL 77.5603 mL
5 mM 0.6205 mL 3.1024 mL 6.2048 mL 12.4096 mL 15.5121 mL
10 mM 0.3102 mL 1.5512 mL 3.1024 mL 6.2048 mL 7.756 mL
50 mM 0.062 mL 0.3102 mL 0.6205 mL 1.241 mL 1.5512 mL
100 mM 0.031 mL 0.1551 mL 0.3102 mL 0.6205 mL 0.7756 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Berberrubine

Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line.[Pubmed:16797033]

Life Sci. 2006 Aug 1;79(10):949-56.

We examined the effects of Berberrubine, a protoberberine alkaloid, on interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) expression in a human retinal pigment epithelial cell line (ARPE-19) stimulated with interleukin-1beta (IL-1beta) or tumor necrosis factor alpha (TNF-alpha). ARPE-19 cells were cultured to confluence. Berberrubine and IL-1beta or TNF-alpha were added to the medium. IL-8 and MCP-1 protein concentrations were measured using enzyme-linked immunosorbent assay. IL-8 and MCP-1 mRNA were measured by real time polymerase chain reaction. Nuclear factor kappaB (NF-kappaB) translocation was examined by immunofluorescent staining/microscopy. Berberrubine dose-dependently inhibited IL-8 and MCP-1 protein levels in the media and mRNA expression of the cells stimulated with IL-1beta or TNF-alpha. Immunofluorescent staining/microscopy of NF-kappaB in the nucleus of unstimulated cells was faint (51+/-14 arbitrary units). Fluorescein was dense (215+/-42 or 170+/-24 arbitrary units, respectively) 30 min after stimulation with IL-1beta or TNF-alpha and was decreased to 62+/-18 or 47+/-16 arbitrary units, respectively, by Berberrubine. Berberrubine dose-dependently inhibited IL-8 and MCP-1 expression and protein secretion induced by IL-1beta or TNF-alpha. Possibly, the effect on chemotactic factors may be via suppression of NF-kappaB translocation.

Antitumor activity of berberrubine derivatives.[Pubmed:964560]

Gan. 1976 Apr;67(2):321-5.

The antitumor activity of berberine, Berberrubine, and their derivatives against sarcoma-180 ascites was determined by the total packed cell volume method. Berbine and tetrahydroberberine derivatives had no antitumor activity, but Berberrubine (9-demethylberberine) and the ester derivatives of Berberrubine had a strong antitumor activity. ED90 of Berberrubine, its acetate and benzoate, were 15, 23, and 44 mg/kg, respectively. The therapeutic indices (LD10/ED90 by the present method) of these compounds were as follows: Berberrubine hydrochloride, 6.7 approximately 9.4; 9-acetyl-9-demethylberberine (9-acetylBerberrubine) chloride, 7.6 approximately 8.7; 9-benzoyl-9-demethylberberine (9-benzoylBerberrubine) chloride, 3.4 approximately 4.9.

Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.[Pubmed:20673726]

Bioorg Med Chem. 2010 Sep 1;18(17):6422-8.

In order to enhance oral bioavailability of berberine (BBR) for its cholesterol-lowering efficacy in vivo, a series of ester or ether prodrugs of Berberrubine (M1), which is an active metabolite of BBR after first-pass metabolism, were designed, semi-synthesized, and evaluated. Among these M1 prodrugs, compound 5g possessing palmitate at the 9-position showed a moderate LogP value and esterase hydrolysis rate for releasing M1 in blood. Its cholesterol-lowering efficacy in vivo was evaluated in hyperlipidemic SD rats. Compound 5g (100mg/kg/d) reduced blood CHO and LDL-c by 35.8% and 45.5%, respectively, similar to that by BBR. It also exhibited a good safety in rats with no side-effect on liver and kidney function. Therefore, the design of M1 prodrug appears to be an effective strategy to improve pharmacokinetic feature of BBR for its lipid-lowering efficacy in vivo.

Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabetics.[Pubmed:24613165]

Bioorg Med Chem Lett. 2014 Apr 1;24(7):1762-5.

By introducing various amino methyl groups into 12-position of Berberrubine, a series of 12-(substituted aminomethyl) Berberrubine derivatives were synthesized and evaluated for their anti-diabetic activity against type 2 diabetes mellitus. The results indicated that most of the prepared compounds exhibited moderate to good anti-diabetic activity, which were comparable to or even better than the berberine, the positive control rosiglitazone and insulin. Especially, compound 3b with an N-methyl piperazine-4-methyl group at C-12, exerted the most powerful anti-diabetic activity.

Description

Berberrubine chloride is an active metabolite of berberine, attenuates ulcerative colitis in mice model.

Keywords:

Berberrubine,15401-69-1,9-Berberoline chloride; Beroline chloride; 9-Demethoxy 9-hydroxyberberinium chloride,Natural Products, buy Berberrubine , Berberrubine supplier , purchase Berberrubine , Berberrubine cost , Berberrubine manufacturer , order Berberrubine , high purity Berberrubine

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: